Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
US federal and state officials said that Shire Pharmaceuticals (LON:SHP, NASDAQ:SHPG) will pay $350m to settle allegations that it used “kickbacks and other unlawful methods” to induce doctors to use a product aimed at treating foot ulcers.
Shire had already announced in August last year that it would settle for the amount during publication of its second-quarter results.
Shire’s ADRs were down 4.4% to $169.50 on Wall Street on Wednesday.
Story by ProactiveInvestors